CPIX Annual Total Liabilities
$52.52 M
-$4.43 M-7.79%
31 December 2023
Summary:
As of January 22, 2025, CPIX annual total liabilities is $52.52 million, with the most recent change of -$4.43 million (-7.79%) on December 31, 2023. During the last 3 years, it has risen by +$2.93 million (+5.90%). CPIX annual total liabilities is now -8.07% below its all-time high of $57.12 million, reached on December 31, 2018.CPIX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPIX Quarterly Total Liabilities
$52.28 M
-$208.90 K-0.40%
30 September 2024
Summary:
As of January 22, 2025, CPIX quarterly total liabilities is $52.28 million, with the most recent change of -$208.90 thousand (-0.40%) on September 30, 2024. Over the past year, it has dropped by -$238.10 thousand (-0.45%). CPIX quarterly total liabilities is now -12.03% below its all-time high of $59.43 million, reached on March 31, 2019.CPIX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPIX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.8% | -0.5% |
| 3 y3 years | +5.9% | +27.7% |
| 5 y5 years | -8.1% | -2.2% |
CPIX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.8% | +25.5% | -8.2% | +24.9% |
| 5 y | 5-year | -7.8% | +25.5% | -8.2% | +27.7% |
| alltime | all time | -8.1% | +1233.0% | -12.0% | +528.2% |
Cumberland Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $52.28 M(-0.4%) |
| June 2024 | - | $52.49 M(-3.4%) |
| Mar 2024 | - | $54.32 M(+3.4%) |
| Dec 2023 | $52.52 M(-7.8%) | $52.52 M(+0.8%) |
| Sept 2023 | - | $52.10 M(-0.8%) |
| June 2023 | - | $52.54 M(-1.7%) |
| Mar 2023 | - | $53.42 M(-6.2%) |
| Dec 2022 | $56.95 M(+36.1%) | $56.95 M(+8.9%) |
| Sept 2022 | - | $52.29 M(-1.9%) |
| June 2022 | - | $53.31 M(-4.6%) |
| Mar 2022 | - | $55.90 M(+33.6%) |
| Dec 2021 | $41.86 M(-15.6%) | $41.86 M(+2.3%) |
| Sept 2021 | - | $40.92 M(-0.3%) |
| June 2021 | - | $41.04 M(-11.7%) |
| Mar 2021 | - | $46.47 M(-6.3%) |
| Dec 2020 | $49.59 M(-7.2%) | $49.59 M(+3.0%) |
| Sept 2020 | - | $48.17 M(-1.9%) |
| June 2020 | - | $49.11 M(+3.2%) |
| Mar 2020 | - | $47.58 M(-11.0%) |
| Dec 2019 | $53.46 M(-6.4%) | $53.46 M(+2.7%) |
| Sept 2019 | - | $52.06 M(-3.3%) |
| June 2019 | - | $53.86 M(-9.4%) |
| Mar 2019 | - | $59.43 M(+4.0%) |
| Dec 2018 | $57.12 M(+94.9%) | $57.12 M(+93.7%) |
| Sept 2018 | - | $29.49 M(-4.2%) |
| June 2018 | - | $30.77 M(+1.8%) |
| Mar 2018 | - | $30.22 M(+3.1%) |
| Dec 2017 | $29.31 M(+44.5%) | $29.31 M(+15.2%) |
| Sept 2017 | - | $25.43 M(+19.4%) |
| June 2017 | - | $21.31 M(+8.4%) |
| Mar 2017 | - | $19.65 M(-3.1%) |
| Dec 2016 | $20.28 M(+34.3%) | $20.28 M(+21.8%) |
| Sept 2016 | - | $16.65 M(+23.2%) |
| June 2016 | - | $13.51 M(-2.7%) |
| Mar 2016 | - | $13.89 M(-8.0%) |
| Dec 2015 | $15.10 M | $15.10 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $14.52 M(+2.1%) |
| June 2015 | - | $14.21 M(+10.7%) |
| Mar 2015 | - | $12.85 M(-12.3%) |
| Dec 2014 | $14.65 M(+76.1%) | $14.65 M(+12.5%) |
| Sept 2014 | - | $13.02 M(+2.2%) |
| June 2014 | - | $12.74 M(+4.9%) |
| Mar 2014 | - | $12.15 M(+45.9%) |
| Dec 2013 | $8.32 M(-36.1%) | $8.32 M(-24.2%) |
| Sept 2013 | - | $10.98 M(-12.8%) |
| June 2013 | - | $12.59 M(-5.0%) |
| Mar 2013 | - | $13.25 M(+1.7%) |
| Dec 2012 | $13.03 M(+2.7%) | $13.03 M(-4.2%) |
| Sept 2012 | - | $13.60 M(+11.8%) |
| June 2012 | - | $12.17 M(-4.3%) |
| Mar 2012 | - | $12.72 M(+0.3%) |
| Dec 2011 | $12.68 M(-11.5%) | $12.68 M(+0.5%) |
| Sept 2011 | - | $12.62 M(-4.1%) |
| June 2011 | - | $13.16 M(-0.3%) |
| Mar 2011 | - | $13.19 M(-8.0%) |
| Dec 2010 | $14.34 M(-54.5%) | $14.34 M(-6.2%) |
| Sept 2010 | - | $15.28 M(-34.7%) |
| June 2010 | - | $23.40 M(-6.4%) |
| Mar 2010 | - | $25.00 M(-20.6%) |
| Dec 2009 | $31.50 M(+132.2%) | $31.50 M(+1.6%) |
| Sept 2009 | - | $31.00 M(+130.1%) |
| June 2009 | - | $13.47 M(+7.5%) |
| Mar 2009 | - | $12.53 M(-7.6%) |
| Dec 2008 | $13.56 M(+11.4%) | $13.56 M(+46.3%) |
| Sept 2008 | - | $9.27 M(+1.8%) |
| June 2008 | - | $9.10 M(-26.6%) |
| Mar 2008 | - | $12.40 M(+1.8%) |
| Dec 2007 | $12.17 M(-20.7%) | $12.17 M(-0.9%) |
| Sept 2007 | - | $12.29 M(-9.6%) |
| June 2007 | - | $13.58 M(-7.2%) |
| Mar 2007 | - | $14.63 M(-4.7%) |
| Dec 2006 | $15.36 M(+289.8%) | $15.36 M |
| Dec 2005 | $3.94 M | - |
FAQ
- What is Cumberland Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual total liabilities year-on-year change?
- What is Cumberland Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly total liabilities year-on-year change?
What is Cumberland Pharmaceuticals annual total liabilities?
The current annual total liabilities of CPIX is $52.52 M
What is the all time high annual total liabilities for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual total liabilities is $57.12 M
What is Cumberland Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, CPIX annual total liabilities has changed by -$4.43 M (-7.79%)
What is Cumberland Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CPIX is $52.28 M
What is the all time high quarterly total liabilities for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly total liabilities is $59.43 M
What is Cumberland Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CPIX quarterly total liabilities has changed by -$238.10 K (-0.45%)